The PROpel clinical trial exploring olaparib plus abiraterone in mCRPC VJOncology 1:45 2 years ago 598 Далее Скачать
PROpel: olaparib plus abiraterone as 1L treatment for metastatic CRPC VJOncology 3:07 2 years ago 810 Далее Скачать
Elucidating HRRm status in patients with mCRPC in the PROpel trial VJOncology 3:47 2 years ago 101 Далее Скачать
PROpel: Final OS of First-Line Abiraterone Plus Olaparib for mCRPC GU Oncology Now 4:08 1 year ago 332 Далее Скачать
Fred Saad, ESMO 2022: Phase III PROpel trial of abiraterone+olaparib in prostate cancer Touch Medical Media 4:56 2 years ago 432 Далее Скачать
Add-on PARP inhibition in metastatic CRPC: PROpel and MAGNITUDE | David VanderWeele Medicine Matters oncology 5:20 2 years ago 297 Далее Скачать
PROpel: gene-by-gene efficacy of olaparib and abiraterone in mCRPC VJOncology 0:44 10 months ago 63 Далее Скачать
PROpel: analysis of drug interactions between olaparib + abiraterone as 1L therapy in mCRPC VJOncology 0:51 2 years ago 142 Далее Скачать
HRQoL and pain outcomes in mCRPC: abi + ala vs abi + pbo in PROpel VJOncology 1:27 1 year ago 72 Далее Скачать
Recent advances in mHSPC: 177Lu-PSMA-617, PROpel and biomarker-directed strategies VJOncology 1:37 2 years ago 69 Далее Скачать
Unlocking Clinical Trial Success: How SPaaS Can Propel Your Research Forward GCP-Mindset - All About Clinical Research 4:52 1 year ago 212 Далее Скачать
Promising Results in Clinical Trials Propel Pharma Stocks #Novavax #COVID19Vacc tester 🎧 0:33 4 months ago 7 Далее Скачать
Propel a Cure Interview with Dr. Jean-Frédéric Colombel Propel a Cure for Crohn's Disease 54:16 4 months ago 314 Далее Скачать
Dr Vamshi Krishna | TALAPRO-2: Final overall survival (OS) in PROpel CRSF - Cancer Research and Statistic Foundation 14:54 1 year ago 28 Далее Скачать
